PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function

REFERENCES

• Casadei S, et al. 2011. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res. 71:2222–2229.
   PubMed Web of Science ®Google Scholar
• Chen P, et al. 2008. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study. Clin. Cancer Res. 14:5931–5937.
   PubMed Web of Science ®Google Scholar
• Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. 2004. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 24:8477–8486.
   PubMed Web of Science ®Google Scholar
• Erkko H, et al. 2007. A recurrent mutation in PALB2 in Finnish cancer families. Nature 446:316–319.
   PubMedGoogle Scholar
• Furukawa M, Xiong Y. 2005. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell. Biol. 25:162–171.
   PubMed Web of Science ®Google Scholar
• Hayes JD, McMahon M. 2009. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem. Sci. 34:176–188.
   PubMed Web of Science ®Google Scholar
• Jones S, et al. 2009. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324:217.
   PubMed Web of Science ®Google Scholar
• Kobayashi A, et al. 2004. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24:7130–7139.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, et al. 2002. Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system. Genes Cells 7:807–820.
   PubMed Web of Science ®Google Scholar
• Li W, Kong AN. 2009. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 48:91–104.
   PubMed Web of Science ®Google Scholar
• Li W, et al. 2010. An internal ribosomal entry site mediates redox-sensitive translation of Nrf2. Nucleic Acids Res. 38:778–788.
   PubMed Web of Science ®Google Scholar
• Lo SC, Li X, Henzl MT, Beamer LJ, Hannink M. 2006. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J. 25:3605–3617.
   PubMed Web of Science ®Google Scholar
• Malhotra D, et al. 2010. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res. 38:5718–5734.
   PubMed Web of Science ®Google Scholar
• McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD. 2006. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a “tethering” mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J. Biol. Chem. 281:24756–24768.
   PubMed Web of Science ®Google Scholar
• Moynahan ME, Jasin M. 2010. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat. Rev. 11:196–207.
   Google Scholar
• Nioi P, Nguyen T. 2007. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem. Biophys. Res. Commun. 362:816–821.
   PubMed Web of Science ®Google Scholar
• Ohta T, et al. 2008. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68:1303–1309.
   PubMed Web of Science ®Google Scholar
• Oliver AW, Swift S, Lord CJ, Ashworth A, Pearl LH. 2009. Structural basis for recruitment of BRCA2 by PALB2. EMBO Rep. 10:990–996.
   PubMed Web of Science ®Google Scholar
• Padmanabhan B, et al. 2006. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21:689–700.
   PubMed Web of Science ®Google Scholar
• Pang Q, Andreassen PR. 2009. Fanconi anemia proteins and endogenous stresses. Mutat. Res. 668:42–53.
   PubMedGoogle Scholar
• Potapova A, Hoffman AM, Godwin AK, Al-Saleem T, Cairns P. 2008. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Cancer Res. 68:998–1002.
   PubMedGoogle Scholar
• Rahman N, et al. 2007. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39:165–167.
   PubMed Web of Science ®Google Scholar
• Reid S, et al. 2007. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat. Genet. 39:162–164.
   PubMed Web of Science ®Google Scholar
• Singh A, et al. 2006. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3:e420.
   PubMed Web of Science ®Google Scholar
• Slater EP, et al. 2010. PALB2 mutations in European familial pancreatic cancer families. Clin. Genet. 78:490–494.
   PubMed Web of Science ®Google Scholar
• Southey MC, et al. 2010. A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res. 12:R109.
   PubMedGoogle Scholar
• Sun Z, Zhang S, Chan JY, Zhang DD. 2007. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell. Biol. 27:6334–6349.
   PubMed Web of Science ®Google Scholar
• Sy SM, Huen MS, Chen J. 2009. PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc. Natl. Acad. Sci. U. S. A. 106:7155–7160.
   PubMed Web of Science ®Google Scholar
• Taguchi K, Motohashi H, Yamamoto M. 2011. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16:123–140.
   PubMed Web of Science ®Google Scholar
• Tischkowitz M, Xia B. 2010. PALB2/FANCN: recombining cancer and Fanconi anemia. Cancer Res. 70:7353–7359.
   PubMed Web of Science ®Google Scholar
• Tischkowitz M, et al. 2007. Analysis of PALB2/FANCN-associated breast cancer families. Proc. Natl. Acad. Sci. U. S. A. 104:6788–6793.
   PubMedGoogle Scholar
• Tong KI, et al. 2006. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol. Cell. Biol. 26:2887–2900.
   PubMed Web of Science ®Google Scholar
• Tong KI, Kobayashi A, Katsuoka F, Yamamoto M. 2006. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 387:1311–1320.
   PubMed Web of Science ®Google Scholar
• Valko M, et al. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39:44–84.
   PubMed Web of Science ®Google Scholar
• Wang XJ, et al. 2008. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29:1235–1243.
   PubMed Web of Science ®Google Scholar
• Wood LD, et al. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318:1108–1113.
   PubMed Web of Science ®Google Scholar
• Xia B, et al. 2007. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat. Genet. 39:159–161.
   PubMed Web of Science ®Google Scholar
• Xia B, et al. 2006. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell 22:719–729.
   PubMed Web of Science ®Google Scholar
• Zhang DD, Hannink M. 2003. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23:8137–8151.
   PubMed Web of Science ®Google Scholar
• Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. 2004. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24:10941–10953.
   PubMed Web of Science ®Google Scholar
• Zhang F, Fan Q, Ren K, Andreassen PR. 2009. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol. Cancer Res. 7:1110–1118.
   PubMed Web of Science ®Google Scholar
• Zhang F, et al. 2009. PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr. Biol. 19:524–529.
   PubMed Web of Science ®Google Scholar